STERIS plc continues to demonstrate a strong market presence with consistent positive ratings from analysts. The company's extensive portfolio in infection prevention and its global operational reach provide a resilient business model. Current analyst sentiment holds a predominantly positive view, reinforcing confidence in its future growth prospects.
The latest analyst ratings for STERIS plc show a stable outlook with no negative sentiment as of July 2026. The distribution of recommendations indicates a balanced view with slight preference towards positive ratings:
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 3 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 0 |
The analyst sentiment over recent months for STERIS plc remains largely positive. Here's a detailed look:
SENTIMENT PERCENTAGE
Observations reveal a trend of stable positive sentiment with a slight increase in Hold ratings over the past year.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-05-13 | Overweight | Overweight | Keybanc |
| 2025-08-08 | Overweight | Overweight | Morgan Stanley |
| 2025-07-22 | Overweight | Overweight | Keybanc |
| 2025-07-15 | Overweight | Equal Weight | Morgan Stanley |
| 2025-05-19 | Equal Weight | Equal Weight | Morgan Stanley |
Recent changes in analyst opinions for STERIS plc are as follows:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-15 | Overweight | Equal Weight | Morgan Stanley |
| 2024-10-24 | Overweight | Neutral | Piper Sandler |
| 2023-04-14 | Neutral | Overweight | Piper Sandler |
| 2022-09-23 | Hold | Buy | Needham |
| 2021-05-26 | Buy | Hold | Needham |
The overall assessment of STERIS plc’s stock ratings and analyst sentiment suggests stability and confidence in the company’s operations and market position. While analyst opinions have remained mostly consistent, slight adjustments indicate ongoing evaluation of market conditions. The absence of negative ratings reinforces trust in the company's prospects. Analysts show a continued interest in the company's ability to perform, with no evident signs of increased uncertainty.
In summary, STERIS plc continues to exhibit resilience and potential for growth within its sector. The stable and largely positive analyst ratings signify a strong foundation, with minimal risk apparent in current evaluations. The company's ability to maintain confidence in fluctuating market conditions highlights its adaptability and market strength, providing a solid investment opportunity with manageable risks in the near term.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.